CXCR4 inhibition with AMD3100 and G-CSF supports stem cell mobilisation in Multiple Myeloma (MM) and non-Hodgkin lymphoma (NHL) [386,387]. The gene discussed is CSF3; the disease is non-Hodgkin lymphoma.